Pubblicazioni

2020

• Campodonico F, Ennas M, Di Domenico A, Benelli A, Brusasco C, Introini C. Concerns in Redirecting Uro-oncologic Patients During COVID-19 Pandemic. Urology. 2020 Jun 3:S0090-4295(20)30637-3. doi: 10.1016/j.urology.2020.05.038. Epub ahead of print.
• Matos J, Paparo F, Calcagno T, Marinaro E, Introini C, Rollandi GA. Solitary Fibrous Tumor of the Prostate. Urology. 2020 Jul;141:e43-e44.
• Paparo F, Peirano A, Matos J, Bacigalupo L, Rossi U, Mussetto I, Bottoni G, Ugolini M, Introini C, Ruggieri FG, Rollandi GA, Piccardo A. Diagnostic value of retrospectively fused 64 CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18 F-Choline PET/MRI, 64 CuCl2 PET/CT, 18 F-Choline PET/CT, and mpMRI. Abdom Radiol (NY). 2020 May 25.

2019

• Campodonico F, Calcagno T, Bacigalupo L, La Camera A, Durante A, Introini C. [Flexible cystoscope for the treatment of urinary stones in intestinal reservoirs.]. Arch Esp Urol. 2019 Nov;72(9):965-967.58

• Finazzi Agrò E, Gregori A, Bianchi D, Carone R, Giammò A, Ammirati E, Giovannelli V, Romanò AL, Martino P, Saracino A, Volpe A, Favro M, Canepa G, Varca V, Pinto A, Farullo G. Efficacy and safety of adjustable balloons (Proact™) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study. Neurourol Urodyn. 2019 Sep;38(7):1979-1984.
• Giammò A, Ammirati E, Tullio A, Morgia G, Sandri S, Introini C, Canepa G, Timossi L, Rossi C, Mozzi C, Carone R. Implant of ATOMS® system for the treatment of postoperative male stress urinary incontinence: an Italian multicentric study. Minerva Urol Nefrol. 2019 Nov 4.  [Epub ahead of print]

2018

• Campodonico F, Ennas M, Introini C. Re: Ettore Di Trapani, Alessandro Nini, Irene Locatelli, et al. Development of the First Model of Radical Prostatectomy in the Mouse: A Feasibility Study. Eur Urol 2018;73:482-4. Eur Urol. 2018 May;73(5):e133.
• Piccardo A, Paparo F, Puntoni M, Righi S, Bottoni G, Bacigalupo L, Zanardi S,  DeCensi A, Ferrarazzo G, Gambaro M, Ruggieri FG, Campodonico F, Tomasello L, Timossi L, Sola S, Lopci E, Cabria M. (64)CuCl(2) PET/CT in Prostate Cancer Relapse. J Nucl Med. 2018 Mar;59(3):444-451.

2017

• Campodonico F, Di Stasi S, Lev GM, Terrone C, Bongiovanni L, Mattioli F, Pagliarulo V, Introini C. Intravesical chemotherapy and chemohypherthermia in non-muscle-invasive bladder cancer; an overview on drug administration technologies and pharmacokinetics. Curr Drug Metab. 2017 Apr 26

2016

• Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol. 2016 Jun;69(6):1046-52.
• Campodonico F, Paparo F, Calcagno T, Capponi G, Conzi G. Renal trauma inadolescent skateboarders. Arch Esp Urol. 2016 Nov;69(9):662-665

2015

• Campodonico F. Re: Han et al.: Factors associated with continuing medical therapy after transurethral resection of prostate (Urology 2014;84:675-680). Urology. 2015 Jan;85(1):275.
• Paparo F, Piccardo A, Bacigalupo L, Romagnoli A, Piccazzo R, Monticone M, Cevasco L, Campodonico F, Conzi GM, Carmignani G, Rollandi GA. Value of bimodal (18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment  of prostate cancer recurrence after radiation therapy and radical prostatectomy.  Abdom Imaging. 2015 Jan 13. [Epub ahead of print]

2014

• Cai T, Tiscione D, Verze P, Pomara G, Racioppi M, Nesi G, Barbareschi M, Brausi M, Gacci M, Luciani LG, Liguori G, Gontero P, Campodonico F, Simonato A, Boddi V, Di Stasi SM, Colombo R, Serretta V, Carmignani G, Malossini G, Altieri V, Carini M, Terrone C, Bassi P, Montorsi F, Ficarra V, Selli C, Mirone V, Bartoletti R. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens. Urology. 2014 Nov;84(5):1141-6.
• Campodonico F, Manuputty EE, Campora S, Puntoni M, Maffezzini M. Age is predictive of immediate postoperative urinary continence after radical retropubic prostatectomy. Urol Int. 2014;92(3):276-81.
• Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A. Recurrence and progression  in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading. Int J Urol. 2014 Oct;21(10):968-72.
• Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A. Response to Editorial Comment from Dr Todenhöfer and Dr Schwentner to Recurrence and progression in patients with non-muscle invasive bladder cancer: Prognostic models including multicolor fluorescence in situ hybridization molecular grading. Int J Urol. 2014 Oct;21(10):974.
• Maffezzini M, Campodonico F, Canepa G, Manuputty EE, Tamagno S, Puntoni M. Intravesical mitomycin C combined with local microwave hyperthermia in non-muscle-invasive bladder cancer with increased European Organization for Research and Treatment of Cancer (EORTC) score risk of recurrence and progression. Cancer Chemother Pharmacol. 2014 May;73(5):925-30.
• Racioppi M, Salmaso L, Brombin C, Arboretti R, D'Agostino D, Colombo R, Serretta V, Brausi M, Casetta G, Gontero P, Hurle R, Tenaglia R, Altieri V, Bartoletti R, Maffezzini M, Siracusano S, Morgia G, Bassi PF. The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome. Urol Int. 2015;94(3):262-9.

2013

• Campodonico F. [Urine cytology and new markers. Are there any advantages in terms of cost-effectiveness?]. Urologia. 2013;80 Suppl 21:7-10. Italian.
• Campodonico F, Parodi D. Re: Lambert et al.: Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer (Urology 2013;81:587-592). Urology. 2013 Jun;81(6):1382.
• Maffezzini M. Feeding Hungry Patients, Even Those Well Nourished. Eur Urol. 2013 Mar;63(3):483-5.
• Maffezzini M. Words of Wisdom: re: trends in hospital volume and operative mortality for high-risk surgery. Eur Urol. 2013 Mar;63(3):582.
• Maffezzini M, Campodonico F, Manuputty EE, Puntoni M, Martelli A, Marini V, Tamagno S, Mattioli F. Systemic Absorption and Pharmacokinetics of Single-dose Early Intravesical Mitomycin C After Transurethral Resection of Non-muscle-invasive Bladder Cancer. Urology. 2013 Jun 20.
• Montironi R, Bartels PH, DeCensi A, Puntoni M, Hurle R, Decobelli O, Carmignani G, Mazzucchelli R, Bartels HG, Alberts DS, Maffezzini M. A randomized  phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in  men with prostate cancer. Efficacy monitored by karyometry. Urol Oncol. 2013 Jul;31(5):557-65.
• Paparo F, Campodonico F, Piccazzo R, Rollandi GA, Maffezzini M. A case of spontaneous rupture of the renal pelvis initially misdiagnosed as a ruptured aneurysm of the abdominal aorta. J Emerg Med. 2013 May;44(5):e365-7.

2012

• Campodonico F, Manuputty EE. Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int. 2012 Nov;110(9):E430.
• Maffezzini M, Campodonico F, Capponi G, Manuputty E, Gerbi G. Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch. Surg Oncol. 2012 Sep;21(3):191-5.
• Simonato A, Varca V, Gacci M, Gontero P, De Cobelli O, Maffezzini M, Salvioni R, Carini M, Decensi A, Mirone V, Carmignani G. Adherence to Guidelines among Italian Urologists on Imaging Preoperative Staging of Low-Risk Prostate Cancer: Results from the MIRROR (Multicenter Italian Report on Radical Prostatectomy Outcomes and Research) Study. Adv Urol. 2012;2012:651061.
• Spatafora S, Casarico A, Fandella A, Galetti C, Hurle R, Mazzini E, Niro C, Perachino M, Sanseverino R, Pappagallo GL; for the AURO.it BPH Guidelines Committee. Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated  summary from AURO.it. Ther Adv Urol. 2012 Dec;4(6):279-301.
• Tunn UW, Canepa G, Kochanowsky A, Kienle E. Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):296-302.
• Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M, Franks KN; RARECARE working group. Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer. 2012 Mar;48(4):456-64.

2011

• Gontero P, Oderda M, Altieri V, Bartoletti R, Cai T, Colombo R, Curotto A, Di Stasi S, Maffezzini M, Tamagno S, Serretta V, Sogni F, Terrone C, Tizzani A, Morgia G, Mirone V, Carmignani G. Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. Urol Int. 2011 Feb;86(1):19-24.
• Halachmi S, Moskovitz B, Maffezzini M, Conti G, Verweij F, Kedar D, Sandri SD, Nativ O, Colombo R. Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder. Urol Oncol. 2011 May-Jun;29(3):259-64.
• Maffezzini M. For wider acceptance of radical cystectomy and extended pelvic lymphadenectomy. Eur Urol. 2011 Feb;59(2):211-2.
• Montironi R, Bartels PH, Decensi A, Puntoni M, Hurle R, Decobelli O, Carmignani G, Mazzucchelli R, Bartels HG, Alberts DS, Maffezzini M. A  randomized  phase IIb presurgical study of finasteride vs. low-dose flutamide vs.  placebo in men with prostate cancer. Efficacy monitored by karyometry☆. Urol Oncol. 2011 Jul 21.

2010

• Campodonico F, Maffezzini M. Active surveillance in young patients with prostate cancer: the unanswered question. J Clin Oncol. 2010 May 1;28(13):e211; author reply e212.
• Gontero P, Oderda M, Altieri V, Bartoletti R, Cai T, Colombo R, Curotto A, Di Stasi S, Maffezzini M, Tamagno S, Serretta V, Sogni F, Terrone C, Tizzani A, Morgia G, Mirone V, Carmignani G. Are Referral Centers for Non-Muscle-InvasiveBladder Cancer Compliant to EAU Guidelines? A Report from the Vesical AntiblasticTherapy Italian Study. Urol Int. 2010 Dec 30
• Maffezzini M, Campodonico F, Capponi G, Canepa G, Casazza S, Bandelloni R, Tamagno S, Puntoni M. Prognostic Significance of Fluorescent In Situ Hybridisation in the Follow-up of Non-muscle-invasive Bladder Cancer. Anticancer Res. 2010 Nov;30(11):4761-5.
• Maffezzini M. For Wider Acceptance of Radical Cystectomy and Extended Pelvic Lymphadenectomy. Eur Urol. 2010 Nov 10.
• Maffezzini M. Words of Wisdom. Re: urinary diversion and morbidity after radical cystectomy for bladder cancer. Eur Urol. 2010 Jun;57(6):1116.
• Puzone R, Paleari L, Montefiore F, Ruggiero L, Puntoni M, Maffezzini M, Bobbio B, Marroni P, Libener R, Betta PG. Osteopontin plasma level does not detect prostate cancer in patients referred for diagnostic prostate biopsy. Int J Biol Markers. 2010 Oct-Dec;25(4):200-6

2009

• Campodonico F, Capponi G, Maffezzini M.
  Re: Cloutier V, Capitanio U, Zini L, et al. Thirty-Day Mortality after Nephrectomy: Clinical Implications for Informed Consent. Eur Urol. 2009 Mar 14.
• Canepa G, Conzi G, Capponi G, Campodonico F, Maffezzini M.
  Short-time ureteral catheterization after operative ureteroscopic lithotripsy: an alternative to stent versus no stent evaluated in a retrospective study. Arch Ital Urol Androl. 2009 Mar;81(1):43-5.
• Halachmi S, Moskovitz B, Maffezzini M, Conti G, Verweij F, Kedar D, Sandri SD, Nativ O, Colombo R.
  Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder. Urol Oncol. 2009 Apr 21.
• Maffezzini M.
  The magnitude of the problem and the burden of physicians and patient decisions. Surg Oncol. 2009 Sep;18(3):183-4.
• Zanardi S, Puntoni M, Maffezzini M, Bandelloni R, Mori M, Argusti A, Campodonico F, Turbino L, Branchi D, Montironi R, Decensi A.
  Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies. Cancer Prev Res (Phila Pa). 2009 Apr;2(4):377-84.
• Fusco F, Sicuteri R, Rossi A, Kontodimas S, Haro JM, Imbimbo C, Mirone V; Italian EDOS Study Group.
  Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study. Asian J Androl. 2009 Sep;11(5):629-37.

2008

• Maffezzini M. Editorial comment on: long-term rates of undetectable psa with initial observation and delayed salvage radiotherapy after radical prostatectomy. Eur Urol. 2008 Jul;54(1):95-6
• PACE participants, Audisio RA, Pope D, Ramesh HS, Gennari R, van Leeuwen BL, West C, Corsini G, Maffezzini M, Hoekstra HJ, et all. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol. 2008 Feb;65(2):156-63
• Maffezzini M. High-risk prostate cancer is worth further risk stratification. Eur Urol. 2008 May;53(5):872-3
• Maffezzini M, Campodonico F, Canepa G, Gerbi G, et all. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence  of postoperative ileus. Surg Oncol. 2008 Jul;17(1):41-8. Epub 2007 Oct 24. Review
• Campodonico F. Editorial Comment on: In Vitro Investigations of Tissue-Engineered Multilayered Urothelium Established from Bladder Washings. Eur Urol. 2008 Dec;54(6):1421
• Campodonico F, Casarico A. Re: Comparison of vasovasostomy with conventional microsurgical suture and fibrin adhesive in rats. Int Braz J Urol. 2008 Mar-Apr;34(2):230
• Colombo F, Casarico A. Penile enlargement. Curr Opin Urol. 2008 Nov;18(6):583-8
• Maffezzini M, Capponi G, Casazza S, Campodonico F, Bandelloni R, Puntoni M. The UroVysion F.I.S.H. test compared to standard cytology for surveillance of non-muscle invasive bladder cancer. Arch Ital Urol Androl. 2008 Dec;80(4):127-31

2007

• Maffezzini M. High-Risk Prostate Cancer is Worth Further Risk Stratification. Eur Urol. 2007 Nov 2
• Maffezzini M, Campodonico F, Canepa G, Gerbi G, Parodi D. Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus. Surg Oncol. 2007 Oct 23. [Epub ahead of print]
• Maffezzini M. The survival of patients with bone metastases from renal cell carcinoma. Eur Urol. 2007 Jul;52(1):169
• Maffezzini M, Gerbi G, Campodonico F, Parodi D. Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications. Urology. 2007 Jun; 69(6):1107-11
• Campodonico F, Mattioli F, Manfredi V, Capponi G, Pasquini P, Martelli A, Maffezzini M. Pharmacokinetics and toxicity of an early single intravesical instillation of gemcitabine after endoscopic resection of superficial bladder cancer.  Anticancer Res. 2007 Mar-Apr;27(2):1179-83
• Maffezzini M, Bossi A, Collette L. Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. Eur Urol. 2007 Mar;51(3):605-13; discussion 613
• Maffezzini M, Campodonico F, Canepa G, Capponi G, Fontana V. Short-schedule intravesical gemcitabine with ablative intent in recurrent Ta-T1, G1-G2, low- or intermediate-risk, transitional cell carcinoma of the bladder. Eur Urol. 2007 Apr; 51(4): 956-61
• Maffezzini M. TC incidence increasing: spread the word. Eur Urol. 2007 Mar;51(3):596-7

2006

• Maffezzini M, Campodonico F, Canepa G, Capponi G, Fontana V.
  Short-Schedule Intravesical Gemcitabine With Ablative Intent in Recurrent Ta-T1, G1-G2, Low- or Intermediate-Risk, Transitional Cell Carcinoma of the Bladder. Eur Urol. 2006 Sep 20
• Maffezzini M. TC Incidence Increasing: Spread the Word. Eur Urol. 2006 Aug 28
• Maffezzini M, Gerbi G, Campodonico F, Parodi D. A multimodal perioperative plan for radical cystectomy and urinary intestinal diversion: effects, limits and complications of early artificial nutrition.
  J Urol. 2006 Sep;176(3):945-8; discussion 948-9
• Maffezzini M. Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-77. Eur Urol. 2006 Sep;50(3):623-4; author reply 624-5. Epub 2006 May 4
• Maffezzini M, Campodonico F. Some remarks on a re-do urinary diversion by converting the ileal conduit to an Indiana pouch. Arch Ital Urol Androl. 2006 Jun;78(2):64-6
• Maffezzini M, Campodonico F, Capponi G, Canepa G, Gavazzi L, Calcagno T. Results and complications with the mini-laparotomic incision in 52 consecutive radical retropubic prostatectomies. Arch Ital Urol Androl. 2006 Jun;78(2):61-3
• Campodonico F, Casarico A, Gavazzi L, Calcagno T, Capponi G, Canepa G, Bandelloni R, Maffezzini M. Cancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsy. Arch Ital Urol Androl. 2006 Jun;78(2):39

2005

• Campodonico F, Canepa G, Capponi G, Bozzo L, Maffezzini M. Intravesical gemcitabine in recurrent superficial bladder carcinoma: preliminary results on ablative efficacy and tolerability. Anticancer Res. 2005 May-Jun;25(3c):2381-4
• Maffezzini M, Gavazzi L, Calcagno T, Capponi G, Bandelloni R. Still a place for the classical systematic sextant technique? Cancer detection rates and complications in 1025 consecutive prostatic biopsies. Arch Ital Urol Androl. 2005 Jun;77(2):106-8
• Campodonico F, Bandelloni R, Maffezzini M. Paraganglioma of the prostate in a young adult. Urology. 2005 Sep;66(3):657
• Maffezzini M. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2005 Sep;174(3):1151-2

2004

• Hurle R, Poma R, Maffezzini M, Manzetti A, Piccinelli A, Taverna G, Bellavita P, Graziotti P. A simple mathematical approach to calculate blood loss in radical prostatectomy. Urol Int. 2004;72(2):135-9
• Campodonico F, Benelli R, Michelazzi A, Ognio E, Toncini C, Maffezzini M. Bladder cell culture on small intestinal submucosa as bioscaffold: experimental study on engineered urothelial grafts. Eur Urol. 2004 Oct; 46(4):531-7
• Maffezzini M, Gerbi G, Campodonico F, Parodi D, Capponi G, Spina A, Guerrieri AM. Peri-operative management of ablative and reconstructive surgery for invasive bladder cancer in the elderly. Surg Oncol. 2004 Dec;13(4):197-200